Effects of the novel 6% hydroxyethyl starch 130/0.4 on renal function of recipients in living-related kidney transplantation

Chinese Medical Journal

Volumn 123, Issue 21, 2010, Pages 3079-3083

  Wu, Yan ^a   Wu, An Shi ^a   Wang, Jun ^b   Tian, Ming ^c   Jia, Xin Yuan ^a   Rui, Yan ^a   Yue, Yun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Hydroxyethyl starch; Living related kidney transplantation; Renal function

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; BETA 2 MICROGLOBULIN; CREATININE; GELATIN SUCCINATE; HETASTARCH; N ACETYL BETA GLUCOSAMINIDASE; NITROGEN; OXYGEN; UREA;

ADULT; AGE; ARTERIAL PRESSURE; ARTICLE; BLOOD SAMPLING; BODY SURFACE; BODY WEIGHT; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; ELECTROCARDIOGRAPHY; FEMALE; GRAFT RECIPIENT; HEART INDEX; HEART RATE; HEART STROKE VOLUME; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; MEAN ARTERIAL PRESSURE; OPERATION DURATION; OXYGEN SATURATION; PATIENT SAFETY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; UREA NITROGEN BLOOD LEVEL; URINALYSIS; URINE VOLUME;

ADOLESCENT; ADULT; AGED; FEMALE; HETASTARCH; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 78649252765     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.21.023     Document Type: Article

References (30)

1. Cosio FG, Qiu W, Henry ML, Falkenhain ME, Elkhammas EA, Davies EA, et al. Factors related to donor organ are major determinants of renal allograft function and survival. Transplantation 1996; 62: 1571-1576.
2. Halloran P, Aprile MA. Factors influencing early renal function in cadaver kidney transplants. A case control study. Transplantation 1988; 45: 122-127.
3. Gourishankar S, Jhangri GS, Cockfield SM, Halloran PF. Donor tissue characteristics influence cadaver kidney transplant function and graft survival but not rejection. J Am Soc Nephrol 2003; 14: 493-499.
4. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333-336.
5. Kreimeier U. Pathophysiology of fluid imbalance. Crit Care 2000; 4 (Suppl 2): S3-S7.
6. Collis RE, Collins PW, Gutteridge CN, Kaul A, Newland AC, Williams DM, et al.The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study. Intensive Care Med 1994; 20: 37-41.
7. Boldt J, Heesen M, Müller M, Pabsdorf M, Hempelmann G. The effects of albumin versus hydroxyethyl starch on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 1996; 83: 254-261.
8. Ickx BE, Bepperling F, Melot C, Schulman C, Van der Linden PJ. Plasma substitution effects of a new hydroxyethyl starch 130/0.4 compared with HES 200/0.5 during and after acute normovolaemic haemodilution. Br J Anaesth 2003;91: 196-202.
9. Kasper SM, Meinert P, Kampe S, Görg C, Geisen C, Mehlhorn U, et al. Large dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 2003; 99: 42-47.
10. Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001; 92: 855-862.
11. Gallandat Huet RC, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, et al. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 2000; 47: 1207-1215.
12. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, et al. Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomized study. Lancet 2001; 357: 911-916.
13. Boldt J, Godet G, Bernal W, Wendon JA. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet 2001; 358: 581-583.
14. Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993; 342: 248-249.
15. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620-1622.
16. Peter S, Fokko JW. Perioperative fluid management in renal transplantation: a narrative review of the literature. Transplant International 2006; 19: 947-959.
17. Suttner S, Boldt J. Volume replacement with hydroxyethyl starch: is there an influence on kidney function? Anasthesiol Intensivmed Notfallmed Schmerzther 2004; 39: 71-77.
18. Blasco V, Leone M, Antonini F, Geissler A, Albanèse J, Martin C. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth 2008; 100: 504-508.
19. Hei ZQ, Li XY, Shen N, Pang HY, Zhou SL, Guan JQ. Prognostic values of serum cystatin C and β2 microglobulin, urinary β2 microglobulin and N-acetyl-β-D-glucosaminidase in early acute renal failure after liver transplantation. Chin Med J 2008; 121: 1251-1256.
20. Nolan J. Fluid resuscitation for the trauma patient. Resuscitation 2001; 48: 57-69.
21. Bunn F, Alderson P, Hawkins V. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2003: CD001319.
22. Christoph KH, Stefan MM, Lukas F, Richard K, Michele G, Andreas Z. Stroke Volume and Pulse Pressure variation for prediction of fluid responsiveness in patients undergoing off-pump coronary artery bypass grafting. Chest 2005; 128: 848-854.
23. Wiesenack C, Fiegl C, Keyser A, Prasser C, Keyl C. Assessment of fluid responsiveness in mechanically ventilated cardiac surgical patients. Eur J Anaesthesiol 2005; 22: 658-665.
24. Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P. Safety of HES 130/0.4 (Voluven) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective,randomized,controlled,parallel-group multicentre trial. Eur J Anaesthesiol 2008; 25: 986-994.
25. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005; 44: 681-699.
26. Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 2007; 94: 427-433.
27. Zikria BA, Subbarao C, Oz MC, Shih ST, McLeod PF, Sachdev R, et al. Macromolecules reduce abnormal microvascular permeability in rat limb ischemia-reperfusion injury. Crit Care Med 1989; 17: 1306-1309.
28. Kaplan SS, Park TS, Gonzales ER, Gidday JM. Hydroxyethyl starch reduces leukocyte adherence and vascular injury in the newborn pig cerebral circulation after asphyxia. Stroke 2000; 31: 2218-2223.
29. Oz MC, FitzPatrick MF, Zikria BA, Pinsky DJ, Durán WN. Attenuation of microvascular permeability dysfunction in postischemic striated muscle by hydroxyethyl starch. Microvasc Res 1995; 50: 71-79.
30. Teppo AM, Honkanen E, Ahonen J, Grönhagen-Riska C. Changes of urinary α1-microglobulin in the assessment of prognosis in renal transplant recipients. Transplantation 2000; 70: 1154-1159.